Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7334580

CC(C)(C)N(C(=O)O)c1ccc(C(=O)Nc2ccc3cc(/C=N\N)ccc3c2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESRRG P62508 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MEN1 O00255 5/20 0.39
▸ KMT2A Q03164 5/20 0.39
▸ RAB9A P51151 6/20 0.38
▸ NPC1 O15118 5/20 0.38
▸ LMNA P02545 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ PLAU P00749 2/20 0.36
▸ KCNK3 O14649 1/20 0.35
▸ TRPV1 Q8NER1 2/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ SLC2A1 P11166 1/20 0.35
▸ F2 P00734 1/20 0.34
▸ PLG P00747 1/20 0.34
▸ KLKB1 P03952 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7334595 1.00 ESRRG (0.43) ESRRGKDM4EMAPTMEN1KMT2A
Trifluoroacetic Acid SCHEMBL7334584 0.82 PLAU (0.51) ESRRGPLAUF2PLGKLKB1
Trifluoroacetic Acid SCHEMBL7335899 0.82 PLAU (0.49) ESRRGMEN1KMT2ARAB9ANPC1
SCHEMBL7353519 0.80 NPC1 (0.40) ESRRGKDM4EMAPTMEN1KMT2A
Trifluoroacetic Acid SCHEMBL7337634 0.79 PLAU (0.60) ESRRGMEN1KMT2ARAB9ANPC1
Trifluoroacetic Acid SCHEMBL7335043 0.79 F2 (0.38) KDM4EMAPTMEN1KMT2ARAB9A
Trifluoroacetic Acid SCHEMBL7338119 0.79 PTGS1 (0.48) MEN1KMT2ALMNATDP1PLAU
Trifluoroacetic Acid SCHEMBL7338135 0.79 PTGS1 (0.48) MEN1KMT2ALMNATDP1PLAU
SCHEMBL7337469 0.78 PLAU (0.54) KDM4EMAPTMEN1KMT2ARAB9A
Trifluoroacetic Acid SCHEMBL7344371 0.77 MEN1 (0.50) MEN1KMT2ARAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010049374-A1 Urokinase inhibitors STEELE ANDREW W (US) 2001-12-06 — — US disclosed
US-6284796-B1 NAPHTHAMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-09-04 — — US disclosed
US-6258822-B1 ENZYME INHIBITORS OF NAPHTHALENE AMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-07-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049374-A1 Urokinase inhibitors SERPINE1, PLAU, SERPINB1 ESRRG 3130/4885KDM4E 4285/4885MAPT 3752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback